Physicians recommend that patients with chronic obstructive pulmonary disease (COPD) quit smoking and use steroids, ...

HealthDay News — There is a bidirectional association between rheumatoid arthritis (RA) and chronic obstructive pulmonary disease (COPD), according to a review published online Dec. 1 in Frontiers in ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

You have full access to this article via your institution. Available treatments for COPD are mainly palliative, and there are no therapies available that halt the decline in lung function or the ...

The US Food and Drug Administration (FDA) has accepted a submission from GSK to review a new indication of Nucala (mepolizumab) as an add-on maintenance treatment for chronic obstructive pulmonary ...

The following is a summary of “Effects of pulmonary rehabilitation on respiratory function in mechanically ventilated ...

You must go to a doctor to know for sure whether you have COPD. That’s because there are things to consider for a diagnosis. Some people have asthma and COPD at the same time. If you have ...

Those key challenges impacting the care of respiratory diseases include delays in diagnosis due to the intermittent nature of ...

China approves GSK's Nucala for chronic rhinosinusitis with nasal polyps, adding to its existing uses in asthma and other ...

data from the MATINEE study to support the regulatory review process to obtain a new indication for the use of Nucala (mepolizumab) in chronic obstructive pulmonary disease or COPD. The submission ...

"FDA to review GSK’s Nucala for COPD" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith ...